Pharmacogenetic Testing is available to help guide clinician’s medication decisions for patients being treated for cardiovascular disease, mental health and chronic pain management.

Vancouver, WA – Molecular Testing Labs™ (Molecular™) today announced that COFEPRIS, regulatory body of the Mexican Government, issued health registration for pharmacogenetic testing. COFEPRIS is a decentralized organization of the Department of Health with technical, administrative and operational autonomy, whose mission is to protect the population against sanitary risks, through sanitary regulation, control and promotion under a single command, which provides unity and homogeneity to the policies which are determined.

“We are ecstatic to have obtained such an important health registration,” said Steve Verschoor, Cofounder, Head of Sales. “There is a clinically relevant percentage of allele variations specific to the population of Mexico. Our testing will help to better determine the appropriate drug therapy for individual patients from day one, avoiding the trial and error of empiric therapy.”

The scope of competence for COFEPRIS includes: health related drugs and technologies, products and services (food, beverage, consumer products, etc.), toxic or dangerous substances and environmental risks. This organization serves all the people of Mexico, which is composed of 32 federal entities: 31 states and a “capital city” (Mexico City). With a population of over 120 million people, Mexico is the most populous Spanish-speaking country in the world and the second-most populous country in Latin America after Brazil.

More About Molecular Testing Labs™

Molecular Testing Labs™ is a CLIA and CAP accredited, state-of-the-art, esoteric and reference laboratory. We specialize in high-complexity, molecular testing with an extensive portfolio of services including infectious disease, toxicology, targeted sequencing, single nucleotide polymorphism (SNP) genotyping, Next-Generation Sequencing (NGS), and high resolution immune profiling. Molecular Testing Labs™ offers a variety of clinical trial services comprising of assay development, trial site training, investigator support, and customized reporting. We apply the maximum level of control to obtain the most consistent and highest quality results.

Molecular Testing Labs™ is founded on three guiding principles – Compliance, Innovation and Partnership. For more information, please visit our corporate website – www.moleculartestinglabs.com.

Contact:
Molecular Testing Labs™
14401 SE 1st St,
Vancouver, WA 98684
Ph: 360-693-8850
www.moleculartestinglabs.com